These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 9223727)

  • 1. Needle exchange is not enough: lessons from the Vancouver injecting drug use study.
    Strathdee SA; Patrick DM; Currie SL; Cornelisse PG; Rekart ML; Montaner JS; Schechter MT; O'Shaughnessy MV
    AIDS; 1997 Jul; 11(8):F59-65. PubMed ID: 9223727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak.
    Schechter MT; Strathdee SA; Cornelisse PG; Currie S; Patrick DM; Rekart ML; O'Shaughnessy MV
    AIDS; 1999 Apr; 13(6):F45-51. PubMed ID: 10397556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective cohort study of risk behaviours, retention and loss to follow-up over 5 years among women and men in a needle exchange program in Stockholm, Sweden.
    Karlsson N; Kåberg M; Berglund T; Hammarberg A; Widman L; Ekström AM
    Int J Drug Policy; 2021 Apr; 90():103059. PubMed ID: 33360734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.
    Hyshka E; Strathdee S; Wood E; Kerr T
    Int J Drug Policy; 2012 Jul; 23(4):261-70. PubMed ID: 22579215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum impact of HIV prevention measures targeted at injecting drug users.
    van Ameijden EJ; Coutinho RA
    AIDS; 1998 Apr; 12(6):625-33. PubMed ID: 9583603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New needle and syringe use, and use of needle exchange programmes by street recruited injection drug users in 1993.
    MacGowan RJ; Sterk CE; Long A; Cheney R; Seeman M; Anderson JE
    Int J Epidemiol; 1998 Apr; 27(2):302-8. PubMed ID: 9602414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
    Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
    CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of HIV, hepatitis C and hepatitis B viruses among injection drug users in southwestern China: a 3-year follow-up study.
    Ruan Y; Qin G; Yin L; Chen K; Qian HZ; Hao C; Liang S; Zhu J; Xing H; Hong K; Shao Y
    AIDS; 2007 Dec; 21 Suppl 8():S39-46. PubMed ID: 18172390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada.
    Archibald CP; Ofner M; Strathdee SA; Patrick DM; Sutherland D; Rekart ML; Schechter MT; O'Shaughnessy MV
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):160-6. PubMed ID: 9473018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of HIV infection among drug users in Zuid-Limburg].
    Wiessing LG; Houweling H; Meulders WA; Cerdá E; Jansen M; Sprenger MJ
    Ned Tijdschr Geneeskd; 1995 Sep; 139(38):1936-40. PubMed ID: 7477534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a needle social marketing strategy to control HIV among injecting drug users in China.
    Wu Z; Luo W; Sullivan SG; Rou K; Lin P; Liu W; Ming Z
    AIDS; 2007 Dec; 21 Suppl 8():S115-22. PubMed ID: 18172379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of HIV infection among injecting drug users: indications for a lower rate of progression among those who have frequently borrowed injecting equipment.
    Mientjes GH; van Ameijden EJ; van den Hoek AJ; Goudsmit J; Miedema F; Coutinho RA
    AIDS; 1993 Oct; 7(10):1363-70. PubMed ID: 8267910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users.
    Murray JM; Law MG; Gao Z; Kaldor JM
    Int J Epidemiol; 2003 Oct; 32(5):708-14. PubMed ID: 14559736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
    Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
    AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors associated with sharing syringes among street-recruited injecting drug users].
    Folch C; Meroño M; Casabona J
    Med Clin (Barc); 2006 Oct; 127(14):526-32. PubMed ID: 17145000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
    Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
    Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future face of coinfection: prevalence and incidence of HIV and hepatitis C virus coinfection among young injection drug users.
    Miller CL; Wood E; Spittal PM; Li K; Frankish JC; Braitstein P; Montaner JS; Schechter MT
    J Acquir Immune Defic Syndr; 2004 Jun; 36(2):743-9. PubMed ID: 15167294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional variation in HIV prevalence and risk behaviours in Ontario injection drug users (IDU).
    Millson P; Myers T; Calzavara L; Wallace E; Major C; Degani N
    Can J Public Health; 2003; 94(6):431-5. PubMed ID: 14700242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.